Neogen Corp. buy melinda
Start price
17.11.18
/
50%
€28.63
Target price
22.01.19
€30.22
Performance (%)
-4.58%
End price
22.01.19
€27.32
Summary
This prediction ended on 22.01.19 with a price of €27.32. With a performance of -4.58%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Neogen Corp. | -7.237% | -7.237% | - | - |
iShares Core DAX® | 1.164% | 1.549% | 24.351% | 23.659% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% | 41.786% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% | 6.454% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% | 42.511% |
According to melinda what are the pros and cons of Neogen Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Neogen Corp. diskutieren
SecteurEquipement, fournitures et distribution médicale Agenda 26/03 Publication de résultats
Manufactures and markets medical testing kits
Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety.
It operates through the following segments: Food Safety, Animal Safety, and Corporate.
The Food Safety segment consists of the development, production and marketing of diagnostic test kits, dehydrated culture media and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation.
The Animal Safety segment includes the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors.
The Corporate segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments.
The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety.
It operates through the following segments: Food Safety, Animal Safety, and Corporate.
The Food Safety segment consists of the development, production and marketing of diagnostic test kits, dehydrated culture media and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation.
The Animal Safety segment includes the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors.
The Corporate segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments.
The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
Nombre d'employés : 1 546 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Neogen Corp.
Neogen Corp.
Start price
Target price
Perf. (%)
€35.40
14.12.21
14.12.21
€38.00
14.12.22
14.12.22
-59.89%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Neogen Corp.
Start price
Target price
Perf. (%)
€21.34
04.04.17
04.04.17
€22.32
02.06.17
02.06.17
4.72%
02.06.17
02.06.17
Could be worthwhile Investment >10% per year
Neogen Corp.
Start price
Target price
Perf. (%)
€11.09
28.09.13
28.09.13
€11.75
27.11.13
27.11.13
20.15%
27.11.13
27.11.13
Could be worthwhile Investment >10% per year